Literature DB >> 7538328

The effect of interleukin-4 with or without mast cell growth factor on peripheral blood granulocyte-macrophage colony-forming cells in healthy controls and in myeloproliferative disorders.

T Siitonen1, A Zheng, E R Savolainen, P Koistinen.   

Abstract

The effect of interleukin-4 (IL-4) on peripheral blood (PB) granulocyte-macrophage (GM) progenitors was investigated in the presence and absence of other hematopoietic growth factors, especially the mast cell growth factor (MGF), in eight healthy controls and in 26 patients with myeloproliferative disorders (MPDs) using a clonogenic cell culture assay. In the controls IL-4 was effective alone, stimulating myeloid colony growth in 50%, while MGF had no effect as a single factor. When either IL-4 or MGF was added to the combination of IL-3, GM-CSF, G-CSF, and IL-6, a statistically significant increase in the colony number was observed. The most potent colony formation took place when all these GFs were combined. In the combinations, the effect of IL-4 was additive, while MGF worked synergistically. In the MPDs, IL-4 had no effect at all on the GM progenitors in the whole group of MPDs or on the different subgroups.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538328     DOI: 10.1007/bf01700376

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  32 in total

1.  IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells.

Authors:  C Sillaber; H Strobl; D Bevec; L K Ashman; J H Butterfield; K Lechner; D Maurer; P Bettelheim; P Valent
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

2.  Differential activity of recombinant colony-stimulating factors in supporting proliferation of human peripheral blood and bone marrow myeloid progenitors in culture.

Authors:  D Caracciolo; S Clark; G Rovera
Journal:  Br J Haematol       Date:  1989-07       Impact factor: 6.998

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.

Authors:  H E Broxmeyer; L Lu; S Cooper; R Tushinski; D Mochizuki; B Y Rubin; S Gillis; D E Williams
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

5.  Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit.

Authors:  K Tsuji; K M Zsebo; M Ogawa
Journal:  Blood       Date:  1991-09-01       Impact factor: 22.113

6.  Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.

Authors:  I K McNiece; K E Langley; K M Zsebo
Journal:  Exp Hematol       Date:  1991-03       Impact factor: 3.084

7.  Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.

Authors:  L M Budel; R Delwel; C van Buitenen; H Hoogerbrugge; B Löwenberg
Journal:  Leukemia       Date:  1993-03       Impact factor: 11.528

8.  Effects of interleukin-4 (IL4) on myelopoiesis: studies on highly purified CD34+ hematopoietic progenitor cells.

Authors:  H W Snoeck; F Lardon; D R van Bockstaele; M E Peetermans
Journal:  Leukemia       Date:  1993-04       Impact factor: 11.528

9.  Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells.

Authors:  D Rennick; G Yang; C Muller-Sieburg; C Smith; N Arai; Y Takabe; L Gemmell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

10.  Suppression of chronic myelogenous leukemia colony growth by interleukin-4.

Authors:  Z Estrov; A B Markowitz; R Kurzrock; M Wetzler; H M Kantarjian; A Ferrajoli; J U Gutterman; M Talpaz
Journal:  Leukemia       Date:  1993-02       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.